Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for ...
The Nemaura Medical (NASDAQ:NMRD) Share Price Is Down 63% So Some Shareholders Are Wishing They Sold
Nemaura Medical Inc. (NASDAQ:NMRD) shareholders should be happy to see the share price up 14% in the last week. But that's not enough to compensate for the decline over the last twelve months. Like a ...
Nemaura Medical NMRD is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. Since ...
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical is a medical technology company developing ...
Nemaura Medical, Inc. (NMRD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Nemaura Medical (NASDAQ:NMRD) stock is on the rise Monday despite a lack of news concerning the company. That increase in price comes alongside heavy trading of NMRD stock. As of this writing, more ...
Nemaura Medical Inc. Annual cash flow by MarketWatch. View NMRD net cash flow, operating cash flow, operating expenses and cash dividends.
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results